Related Experiment Video

Updated: Feb 9, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

16.3K

MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease

Christian Koenecke1,2, Andreas Krueger3

  • 1Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

Frontiers in Immunology
|June 6, 2018
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in T-cell function and acute graft-versus-host disease (GvHD). Targeting specific miRNAs in T cells offers a promising strategy for GvHD treatment while preserving graft-versus-tumor effects.

Area of Science:

  • Immunology
  • Molecular Biology
  • Transplantation Medicine

Background:

  • Acute graft-versus-host disease (GvHD) is a significant cause of mortality following allogeneic stem cell transplantation.
  • Donor T-cell recognition of allo-antigens drives GvHD pathogenesis.
  • MicroRNAs (miRNAs) are critical regulators of T-cell development, homeostasis, and activation, influencing pathological T-cell responses in GvHD.

Purpose of the Study:

  • To review the role of specific miRNAs in the pathophysiology of GvHD.
  • To highlight miRNAs acting within T cells that are implicated in GvHD.
  • To explore the therapeutic potential of miRNAs for GvHD management.

Main Methods:

  • Literature review focusing on miRNAs involved in T-cell function and GvHD.
  • Analysis of preclinical models demonstrating the role of specific miRNAs in GvHD.
  • Synthesis of current knowledge on miRNA-mediated regulation of T-cell responses in GvHD.

Main Results:

  • Several key miRNAs have been identified as critical contributors to GvHD development and progression.
  • These miRNAs modulate T-cell activation, differentiation, and effector functions relevant to GvHD.
  • Preclinical studies support the involvement of specific miRNAs in GvHD pathophysiology.

Conclusions:

  • MicroRNAs represent promising therapeutic targets for modulating GvHD.
  • Targeting miRNAs could allow for the curtailment of acute GvHD while preserving essential graft-versus-tumor immunity.
  • Further investigation and clinical translation of miRNA-based therapies for GvHD are warranted.
Keywords:
T celldifferentiationgraft-versus-host diseasegraft-versus-tumor effectmicroRNA

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

16.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
84.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Zygotic Development And Stem Cell Formation01:10

Zygotic Development And Stem Cell Formation

The development of all multicellular organisms starts with the fusion of haploid cells called sperm and egg to form a diploid zygote. A zygote is a totipotent cell that can develop into a complete organism. The zygote undergoes cell division or cleavage to form an 8-cell mass. Until this stage, the cells are spherical, loosely attached, and remain totipotent. Totipotent cells are capable of developing both the embryonic and the extraembryonic tissues. However, as they continue to divide, they...
6.8K